期刊
ADVANCED DRUG DELIVERY REVIEWS
卷 106, 期 -, 页码 172-182出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.addr.2016.06.008
关键词
Cell-penetrating peptides; Nucleic acid delivery; Oligonucleotides; Antisense oligonucleotides; siRNA; Nanoparticles; Splice-switching oligonucleotides; Delivery peptides
资金
- Estonian Research Council [PUTJD71]
- Swedish Institute's Visby program
- Swedish Society of Medical Research (SSMF)
- Swedish Research Council (VR-Med)
- SSMF
- Swedish Research Council (EuroNanoMedII)
Nucleic acids and their synthetic oligonucleotide (ON) analogs are a group of gene therapeutic compounds which hold enormous clinical potential. Despite their undoubted potential, clinical translation of these molecules, however, has been largely held back by their limited bioavailability in the target tissues/cells. To overcome this, many different drug delivery systems have been devised. Among others, short delivery peptides, called cell-penetrating peptides (CPPs), have been demonstrated to allow for efficient delivery of nucleic acids and their ON analogs, in both cell culture and animal models. In this review, we provide brief overview of the latest advances in nucleic acid delivery with CPPs, covering the two main vectorization strategies, covalent conjugation and nanoparticle formation-based approach. In conclusion, CPP-based drug delivery systems have the capacity to overcome the hurdle of delivery and thus have the potential to facilitate the clinical translation of nucleic acid-based therapeutics. (C) 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据